EMILY POULTON: Open Payments
NPI 1154953073 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 6 payments from 6 companies in 2025. Trend: 2023 $440 · 2024 $2,214 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Ethicon US, LLC | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: VRAYLAR, REXULTI, VISTASEAL, REPATHA, AUSTEDO XR.
Industry payments across UT — which companies pay providers there.
